{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:39:51Z","timestamp":1791808791572,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-002-201-MY3"],"award-info":[{"award-number":["111-2314-B-002-201-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["112-S0108"],"award-info":[{"award-number":["112-S0108"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["202002106RIND"],"award-info":[{"award-number":["202002106RIND"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ijantimicag.2023.107019","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T05:09:00Z","timestamp":1698988140000},"page":"107019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-5461","authenticated-orcid":false,"given":"Ting-Yu","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tsung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Fen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-0594","authenticated-orcid":false,"given":"Jung-Yien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.107019_bib0001","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.diagmicrobio.2016.10.005","article-title":"Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations","volume":"87","author":"Montesinos","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0002","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201807-1358ED","article-title":"In search of clinical factors that predict risk for Pneumocystis jirovecii pneumonia in patients without HIV\/AIDS","author":"Limper","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0003","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3201\/eid2009.131668","article-title":"Pneumocystis jirovecii pneumonia in patients with or without AIDS, France","volume":"20","author":"Roux","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0004","article-title":"A model to predict in-hospital mortality in HIV\/AIDS patients with pneumocystis pneumonia in China: the clinical practice in real world","volume":"2019","author":"Wu","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/CMR.00013-12","article-title":"Colonization by Pneumocystis jirovecii and its role in disease","volume":"25","author":"Morris","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.001","article-title":"Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim\/sulfamethoxazole","volume":"55","author":"Chen","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0007","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3109\/13693786.2013.770604","article-title":"Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort","volume":"51","author":"Yoon","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0008","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3201\/eid1010.040362","article-title":"Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia","volume":"10","author":"Stein","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0009","article-title":"Update on dihydropteroate synthase (DHPS) mutations in Pneumocystis jirovecii","volume":"7","author":"de la Horra","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(01)05705-1","article-title":"Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study","volume":"358","author":"Navin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0011","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1051\/parasite\/2010173219","article-title":"Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations","volume":"17","author":"Matos","year":"2010","journal-title":"Parasite"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0012","first-page":"61","article-title":"High prevalence of Pneumocystis jirovecii dihydropteroate synthase gene mutations in patients with a first episode of pneumocystis pneumonia in Santiago, Chile, and clinical response to trimethoprim-sulfamethoxazole therapy","author":"Ponce","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2217\/fmb-2016-0115","article-title":"Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii","volume":"12","author":"Chien","year":"2017","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0014","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1080\/14656566.2021.1915989","article-title":"Pneumocystis jirovecii: a review with a focus on prevention and treatment","volume":"22","author":"Weyant","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0015","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.1987.00370080049012","article-title":"Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome","volume":"147","author":"Kales","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0016","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1378\/chest.91.3.323","article-title":"Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS","volume":"91","author":"DeLorenzo","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0017","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0018","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","article-title":"Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years","volume":"22","author":"Schmidt","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0019","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/13693786.2010.505584","article-title":"Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes in non-HIV-immunocompromised patients: a tertiary care reference health centre study","volume":"49","author":"Tyagi","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0020","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.02102-08","article-title":"Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes","volume":"47","author":"van Hal","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0021","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diagmicrobio.2008.04.016","article-title":"Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality","volume":"62","author":"Alvarez-Martinez","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0022","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijid.2022.07.070","article-title":"Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia","volume":"122","author":"Huang","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0023","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10156-012-0453-0","article-title":"Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies","volume":"18","author":"Tasaka","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0024","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2147\/IDR.S199761","article-title":"Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients","volume":"12","author":"Liu","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0025","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1378\/chest.128.2.573","article-title":"Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features","volume":"128","author":"Festic","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0026","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13613-019-0604-x","article-title":"Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study","volume":"9","author":"Gaborit","year":"2019","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0027","article-title":"Risk factors of mortality from pneumocystis pneumonia in non-HIV patients: a meta-analysis","volume":"9","author":"Wang","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0028","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijid.2019.08.015","article-title":"High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP\/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia","volume":"88","author":"Jin","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0029","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/infdis\/jiw402","article-title":"Interplay between antibiotic resistance and virulence during disease promoted by multidrug-resistant bacteria","volume":"215","author":"Geisinger","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0148607100024006317","article-title":"Cytokine-driven inflammatory response is associated with the hypermetabolism of AIDS patients with opportunistic infections","volume":"24","author":"Garcia-Lorda","year":"2000","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.ijantimicag.2023.107019_bib0031","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/QAD.0000000000002207","article-title":"Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia","volume":"33","author":"Huang","year":"2019","journal-title":"AIDS"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923002935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923002935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:12:13Z","timestamp":1777583533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923002935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0924857923002935"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.107019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107019"}}